Assessing cancer-related cognitive function in the context of everyday life using ecological mobile cognitive testing: A protocol for a prospective quantitative study

Objective Millions of cancer survivors are at risk for cancer-related cognitive impairment (CRCI), yet accurate and accessible assessments of cognitive functioning remain limited. Ecological mobile cognitive testing (EMCT) could offer a solution. This paper presents the protocol for a study that aims to (1) establish the reliability and validity of EMCT to assess CRCI in breast cancer survivors, and (2) prospectively evaluate within-person processes (and interactions) among context, mood, and behavior that explain cognitive variability, everyday functioning, and quality of life of cancer survivors. Methods Participants will include breast cancer survivors (>21 years old) who are within 5 years of completing chemotherapy treatment. Participants will complete two virtual visits (baseline, follow-up) 2 months apart to assess self-reported cognitive symptoms and cognitive performance, sociodemographic characteristics, clinical history, everyday functioning, and quality of life. Between virtual visits, EMCT will be used to sample cognitive functioning every other day (28 times total). We will use linear mixed-effect regressions and single-level multiple regression models to analyze the data. Results We anticipate a minimum of 124 breast cancer survivors enrolling and completing data collection. Study results will be published in peer-reviewed scientific journals. Conclusions Our findings will have broad implications for assessing CRCI in an ecologically valid and person-centered way using EMCT. We aim to provide this protocol to aid researchers who would like to apply this approach to their studies.

[1]  H. Okamura,et al.  A scoping review of cognitive assessment tools and domains for chemotherapy-induced cognitive impairments in cancer survivors , 2023, Frontiers in Human Neuroscience.

[2]  Alexandra M. Gaynor,et al.  Remote, Computerised Cognitive Assessment for Breast Cancer- and Treatment-Related Cognitive Dysfunction: Psychometric Characteristics of the Cogsuite Neurocognitive Battery. , 2023, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[3]  S. Kesler,et al.  Remote assessment of cognitive dysfunction in hematologic malignancies using web‐based neuropsychological testing , 2022, Cancer medicine.

[4]  Alexandra M. Gaynor,et al.  Novel computerized neurocognitive test battery is sensitive to cancer-related cognitive deficits in survivors , 2022, Journal of Cancer Survivorship.

[5]  Philip D. Harvey,et al.  Feasibility and validity of ecological momentary cognitive testing among older adults with mild cognitive impairment , 2022, Frontiers in Digital Health.

[6]  C. Nowinski,et al.  Uses of the NIH Toolbox® in Clinical Samples , 2022, Neurology. Clinical practice.

[7]  Raeanne C. Moore,et al.  Initial Psychometric Properties of 7 NeuroUX Remote Ecological Momentary Cognitive Tests Among People With Bipolar Disorder: Validation Study , 2022, Journal of medical Internet research.

[8]  C. Depp,et al.  Relationships between daily mood states and real-time cognitive performance in individuals with bipolar disorder and healthy comparators: A remote ambulatory assessment study , 2021, Journal of clinical and experimental neuropsychology.

[9]  C. Yuan,et al.  Psychometric evaluation of the PROMIS social function short forms in Chinese patients with breast cancer , 2021, Health and Quality of Life Outcomes.

[10]  N. Lunet,et al.  Trajectories of cognitive performance over five years in a prospective cohort of patients with breast cancer (NEON-BC) , 2021, Breast.

[11]  Y. Roquelaure,et al.  Return to work of breast cancer survivors: toward an integrative and transactional conceptual model , 2021, Journal of Cancer Survivorship.

[12]  A. J. van der Beek,et al.  Trajectories of Cognitive Symptoms in Sick-Listed Cancer Survivors , 2021, Cancers.

[13]  S. Kesler,et al.  Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations from the Cancer Neuroscience Initiative Working Group. , 2021, Journal of the National Cancer Institute.

[14]  Y. T. Cheung,et al.  Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group , 2020, Supportive Care in Cancer.

[15]  Philip D. Harvey,et al.  Remote Ecological Momentary Testing of Learning and Memory in Adults With Serious Mental Illness. , 2020, Schizophrenia bulletin.

[16]  C. Parsey,et al.  BrainCheck: Validation of a Computerized Cognitive Test Battery for Detection of Mild Cognitive Impairment and Dementia , 2020, medRxiv.

[17]  F. André,et al.  Differentiation of groups of patients with cognitive complaints at breast cancer diagnosis: Results from a sub‐study of the French CANTO cohort , 2020, Psycho-oncology.

[18]  Ali Montazeri,et al.  Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018 , 2020, Health and Quality of Life Outcomes.

[19]  J. Grellard,et al.  Perceived Cognitive Impairment in Breast Cancer Survivors and Its Relationships with Psychological Factors , 2020, Cancers.

[20]  S. Kesler,et al.  A randomized control trial of meditation compared to music listening to improve cognitive function for breast cancer survivors: Feasibility and acceptability. , 2020, Complementary therapies in clinical practice.

[21]  Raeanne C. Moore,et al.  Daily Activities Related to Mobile Cognitive Performance in Middle-Aged and Older Adults: An Ecological Momentary Cognitive Assessment Study , 2020, JMIR mHealth and uHealth.

[22]  M. Fitch,et al.  Going beyond (electronic) patient-reported outcomes: harnessing the benefits of smart technology and ecological momentary assessment in cancer survivorship research , 2020, Supportive Care in Cancer.

[23]  Stacey B. Scott,et al.  Memory lapses in daily life among breast cancer survivors and women without cancer history , 2020, Psycho-oncology.

[24]  G. Winocur,et al.  Cancer-Related Cognitive Impairment: An update on state of the art, detection, and management strategies in cancer survivors. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[25]  Stacey B. Scott,et al.  Cognitive performance of breast cancer survivors in daily life: Role of fatigue and depressed mood , 2019, Psycho-oncology.

[26]  J. Fardell,et al.  Why Are Objective and Perceived Cognitive Function Weakly Correlated in Patients With Cancer? , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  D. Eagleman,et al.  A Rapid, Mobile Neurocognitive Screening Test to Aid in Identifying Cognitive Impairment and Dementia (BrainCheck): Cohort Study , 2019, JMIR aging.

[28]  P. Schofield,et al.  Subjective, but not objective, cognitive complaints impact long-term quality of life in cancer patients , 2019, Journal of psychosocial oncology.

[29]  Matthias G. Arend,et al.  Statistical power in two-level models: A tutorial based on Monte Carlo simulation. , 2019, Psychological methods.

[30]  D. Howieson Current limitations of neuropsychological tests and assessment procedures , 2019, The Clinical neuropsychologist.

[31]  H. Dhillon,et al.  Important differences and meaningful changes for the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) , 2018, Journal of Patient-Reported Outcomes.

[32]  L. Minasian,et al.  Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  T. Horowitz,et al.  A Call for a Neuroscience Approach to Cancer-Related Cognitive Impairment , 2018, Trends in Neurosciences.

[34]  H. Dhillon,et al.  Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment , 2018, Journal of Cancer Survivorship.

[35]  S. Kesler,et al.  Modifiable correlates of perceived cognitive function in breast cancer survivors up to 10 years after chemotherapy completion , 2018, Journal of Cancer Survivorship.

[36]  T. Ahles,et al.  New Challenges in Psycho‐Oncology Research IV: Cognition and cancer: Conceptual and methodological issues and future directions , 2018, Psycho-oncology.

[37]  S. Kesler,et al.  Predicting Long-Term Cognitive Outcome Following Breast Cancer with Pre-Treatment Resting State fMRI and Random Forest Machine Learning , 2017, Front. Hum. Neurosci..

[38]  D. Eagleman,et al.  Diagnostic accuracy of tablet-based software for the detection of concussion , 2017, PloS one.

[39]  S. Newman,et al.  Is there a relationship between objectively measured cognitive changes in patients with solid tumours undergoing chemotherapy treatment and their health‐related quality of life outcomes? A systematic review , 2017, Psycho-oncology.

[40]  C. Heckler,et al.  Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  Sunita K. Patel,et al.  Convergent and criterion validity of the CogState computerized brief battery cognitive assessment in women with and without breast cancer , 2017, The Clinical neuropsychologist.

[42]  L. Fallowfield,et al.  Patient-reported outcome measures of the impact of cancer on patients’ everyday lives: a systematic review , 2016, Journal of Cancer Survivorship.

[43]  P. Ganz,et al.  Subjective or Objective Measures of Cognitive Functioning-What's More Important? , 2016, JAMA oncology.

[44]  J. Teresi,et al.  Methodological Issues in Examining Measurement Equivalence in Patient Reported Outcomes Measures: Methods Overview to the Two-Part Series, "Measurement Equivalence of the Patient Reported Outcomes Measurement Information System® (PROMIS®) Short Forms". , 2016, Psychological test and assessment modeling.

[45]  A. Saykin,et al.  Reliable change in neuropsychological assessment of breast cancer survivors , 2016, Psycho-oncology.

[46]  Eileen F. Tallman,et al.  Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument. , 2015, Journal of pain and symptom management.

[47]  Kyle R. Noll,et al.  Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults , 2015, CA: a cancer journal for clinicians.

[48]  T. Marteau,et al.  Executive function in the context of chronic disease prevention: theory, research and practice. , 2014, Preventive medicine.

[49]  L. Mackenzie,et al.  Chemobrain Experienced by Breast Cancer Survivors: A Meta-Ethnography Study Investigating Research and Care Implications , 2014, PloS one.

[50]  J. Anema,et al.  Physical and psychosocial problems in cancer survivors beyond return to work: a systematic review , 2014, Psycho-oncology.

[51]  Shelli R. Kesler,et al.  Prevalence, mechanisms, and management of cancer-related cognitive impairment , 2014, International review of psychiatry.

[52]  J. Zihl,et al.  Telephone-based screening tools for mild cognitive impairment and dementia in aging studies: a review of validated instruments , 2013, Front. Aging Neurosci..

[53]  J. Suls,et al.  New approaches to understand cognitive changes associated with chemotherapy for non-central nervous system tumors. , 2013, Journal of pain and symptom management.

[54]  J. Carpenter,et al.  Impact of perceived cognitive impairment in breast cancer survivors. , 2013, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[55]  N. Bolger,et al.  Intensive Longitudinal Methods: An Introduction to Diary and Experience Sampling Research , 2013 .

[56]  A. Hutchinson,et al.  Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. , 2012, Cancer treatment reviews.

[57]  P. Butow,et al.  Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[58]  T. Ahles,et al.  International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. , 2011, The Lancet. Oncology.

[59]  G. Velikova,et al.  The Social Difficulties Inventory (SDI): development of subscales and scoring guidance for staff , 2011, Psycho-oncology.

[60]  D. Boulware,et al.  Patterns of care and survival in cancer patients with cognitive impairment. , 2010, Critical reviews in oncology/hematology.

[61]  Oscar L. Lopez,et al.  Telephone Interview for Cognitive Status , 2009, Neuroepidemiology.

[62]  S. Subramanian,et al.  Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response , 2009, Journal of cancer survivorship : research and practice.

[63]  M. Sprangers,et al.  The role of neuropsychological functioning in cancer survivors' return to work one year after diagnosis , 2009, Psycho-oncology.

[64]  Masumi Iida,et al.  A Procedure for Evaluating Sensitivity to Within-Person Change: Can Mood Measures in Diary Studies Detect Change Reliably? , 2006, Personality & social psychology bulletin.

[65]  A. Cull,et al.  Development and evaluation of an instrument to assess social difficulties in routine oncology practice , 2005, Quality of Life Research.

[66]  D. Tulsky,et al.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  Philip D. Harvey,et al.  Capturing Clinical Symptoms with Ecological Momentary Assessment: Convergence of Momentary Reports of Psychotic and Mood Symptoms with Diagnoses and Standard Clinical Assessments. , 2021, Innovations in clinical neuroscience.

[68]  J. Teresi,et al.  Measurement Equivalence of the Patient Reported Outcomes Measurement Information System® (PROMIS®) Applied Cognition - General Concerns, Short Forms in Ethnically Diverse Groups. , 2016, Psychological test and assessment modeling.